Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen

Transfusion

Volumn 48, Issue 5, 2008, Pages 814-821

  Clark, David A ^b   Gorczynski, Reginald M ^b   Blajchman, Morris A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD200 ANTIBODY; CD200 ANTIGEN; INTERLEUKIN 10; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FIBROSARCOMA; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFECTION RESISTANCE; MOUSE; NONHUMAN; PERIPHERAL CIRCULATION; SPLEEN CELL; TRANSFUSION RELATED IMMUNOMODULATION; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD11C; BLOOD TRANSFUSION; DENDRITIC CELLS; FEMALE; FIBROSARCOMA; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; ISOANTIGENS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; SPLEEN; TRANSFORMING GROWTH FACTOR BETA;

EID: 42949143517     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01654.x     Document Type: Article

References (41)

1. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973 5 : 253 9.
2. Opelz G, Vanrenterghem Y, Kirste G, Gray DW, Horsburgh T, Lachance JG, Largiader F, Lange H, Vujaklija-Stipanovic K, Alvarez-Grande J, Schott W, Hoyer J, Schnuelle P, Descoeudres C, Ruder H, Wujciak T, Schwarz V. Prospective evaluation of pretransplant blood transfusion in cadaver kidney recipients. Transplantation 1997 63 : 964 7.
3. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal cancer. Br J Surg 1993 80 : 427 32.
4. Vamvakas E, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion 1993 33 : 754 65.
5. Vamvakas EC, Blajchman MA. Transfusion-related immunosuppression (TRIM): an update. Blood Rev 2007 21 : 327 48.
6. Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP. Allogeneic blood-transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993 81 : 1880 92.
7. Bordin J, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of leukodepletion. Blood 1994 84 : 344 8.
8. Thomson AW, Lu L, Murase N, Demetrius AJ, Ruo AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995 13 : 622 39.
9. Yang L, DuTemple B, Khan Q, Zhang L. Mechanisms of long-term donor-specific allograft survival induced by pretransplant infusion of lymphocytes. Blood 1998 91 : 324 30.
10. Prehn RT, Prehn LM. Immunostimulation of cancer versus immunosurveillance. Medicine 1996 56 (Suppl 1 65 73.
11. Bottomly K. T cells and dendritic cells get intimate. Science 1999 283 : 1124 5.
12. Lowry WS, Clark DA, Hanneman JH. Skin cancer and immunosuppression. Lancet 1973 1 : 1290 1.
13. Gianotti L, Pyles T, Alexander JW, Fukushima R, Babcock GF. Identification of the blood component responsible for increased susceptibility to gut-derived infection. Transfusion 1993 33 : 458 65.
14. Gianotti L, Pyles T, Alexander JW, Babcock GF, Carey MA. Impact of blood transfusion and burn injury on microbial translocation and bacterial survival. Transfusion 1992 32 : 312 7.
15. Babcock GF, Alexander JW. The effects of blood transfusion on cytokine production by TH1 and TH2 lymphocytes in the mouse. Transplantation 1996 61 : 465 8.
16. Freda SE, Valente J, Alexander JW, Babcock GF. The relationship of blood transfusion and immunosuppression to the TH1/TH2 paradigm. Transplant Proc 1997 29 : 1153 4.
17. Fast LG. Control of immune responses induced by the transfer of allogeneic white blood cells during transfusion. Transfusion 2005 45 (2 Suppl 44S 50S.
18. Semple JW, Speck ER, Cosgrove D, Lazarus AH, Blanchette VS, Freedman J. Extreme leukoreduction of major histocompatability complex class II positive B cells enhances allogeneic platelet immunity. Blood 1999 93 : 713 20.
19. Slichter SJ, Fish D, Abrams VK, Gaur L, Nelson K, Bolgiano D. Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model. Blood 2005 105 : 847 54.
20. Clark DA, Croitoru K. TH1/TH2 imbalance due to cytokine-producing NK, γδT, and NK-γδT cells in murine pregnancy decidua in success or failure of pregnancy. Am J Reprod Immunol 2001 45 : 257 65.
21. Clark DA, Coulam CB, Daya S, Chaouat G. Unexplained sporadic and recurrent miscarriage in the new millennium: a critical analysis of immune mechanisms. Hum Reprod Update 2001 7 : 501 11.
22. Clark DA, Chaouat G. Immunomodulation by CD200 as a basis for prevention of cytokine-dependent fetal loss syndrome. Am J Reprod Immunol 2003 49 : 350 1.
23. Barclay AN, Wright GJ, Brooke G, Brown MH. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 2002 23 : 285 90.
24. Gorczynski RM, Hadidi S, Yu G, Clark DA. The same immunoregulatory molecules contribute to successful pregnancy and transplantation. Am J Reprod Immunol 2002 48 : 18 26.
25. 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 2004 34 : 1303 11.
26. Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang 1998 74 (Suppl 2 315 9.
27. Nabozny GH, Cobbold SP, Waldmann H, Kong YC. Suppression in murine experimental autoimmune thyroiditis: in vivo inhibition of CD4+ T cell-mediated resistance by a nondepleting rate CD4 monoclonal antibody. Cell Immunol 1991 138 : 185 96.
28. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984 312 : 548 51.
29. Clark DA, Merali FS, Hoskin DW, Steel-Norwood D, Arck PC, Croitoru K, Murgita RA, Hirte H. Decidua-associated suppressor cells in abortion-prone DBA/2-mated CBA/J mice that release bioactive transforming growth factor β2-related immunosuppressive molecules express a bond marrow-derived natural suppressor cell marker and ãδ T-cell receptor. Biol Reprod 1997 56 : 1351 60.
30. Gorczynski L, Chen Z, Hu J, Kai Y, Lei J, Ramakrishna V, Gorczynski RM. Evidence that an OX-2-positive cell can inhibit stimulation of type 1 cytokine production by bone marrow-derived B8-1 (and B7-2) -positive dendritic cells. J Immunol 1999 162 : 774 81.
31. Yrlid U, Cerovic V, Milling S, Jenkens CD, Zhnag J, Crocker PR, Klavinskis LS, MacPherson GG. Plasmacytoid dentritic cells do not migrate in intestinal or hepatic lymph. J Immunol 2006 177 : 6115 21.
32. Gorczynski RM. Transplant tolerance modifying antibody to CD200, but not CD200, alters cytokine production from stimulated macrophages. Eur J Immunol 2001 31 : 2331 7.
33. Gorczynski RM, Lee L, Boudakov I. Augmented induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R. Transplantation 2005 79 : 1180 3.
34. Terness P, Chuang JJ, Opelz G. The immunoregulatory role of IDO-producing dendritic cells revisited. Trends Immunol 2006 27 : 68 73.
35. Wilding G. Response of prostate cancer cells to peptide growth factors: transforming growth factor-β. Cancer Surv 1991 11 : 147 63.
36. Chang NS. Transforming growth factor-β protection of cancer cells against tumor necrosis factor cytotoxicity is counteracted by hyaluronidase. Int J Mol Med 1998 2 : 653 9.
37. Welch DR, Fabra A, Nakajima M. Transforming growth factor-β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci U S A 1990 87 : 7678 82.
38. Reed SG. TGF-β in infections and infectious disease. Microbes Infect 1999 1 : 1313 25.
39. Gianotti L, Pyles T, Alexander JW, Fukushima R, Babcock GE. Identification of the blood component responsible for increased susceptibility to gut-derived infection. Transfusion 1993 33 : 458 65.
40. Eaves-Pyle T, Alexander JW. The effect of blood transfusion on susceptibility to bacterial infection in genetically defined mouse models. J Trauma-Injury Infect Crit Care 1997 43 : 894 8.
41. Clark DA. Tolerance signalling molecules. Chem Immunol Allergy 2005 89 : 36 48.